Skip to Content

Mvasi Prices, Coupons and Patient Assistance Programs

Mvasi (bevacizumab) is a member of the VEGF/VEGFR inhibitors drug class and is commonly used for Cervical Cancer, Colorectal Cancer, Glioblastoma Multiforme, and others.

Mvasi Prices

This Mvasi price guide is based on using the discount card which is accepted at most U.S. pharmacies. The cost for Mvasi intravenous solution (awwb 25 mg/mL) is around $717 for a supply of 4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Intravenous Solution

awwb 25 mg/mL Mvasi intravenous solution
from $716.71 for 4 milliliters
Quantity Per unit Price
4 milliliters $179.18 $716.71
16 milliliters $177.40 $2,838.32

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee. Printable Discount Card

Print Now

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Mvasi Coupons and Rebates

Mvasi offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Mvasi Amgen First Step Program: Eligible commercially insured patients may pay only $5 per dose/cycle with savings of up to $20,000 per calendar year; $0 co-pay on 1st dose/cycle; for additional information contact the program at 888-657-8371.

Applies to:Mvasi
Number of uses:Per prescription until program expires

Patient Assistance Programs for Mvasi

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Amgen FIRST STEP Co-Pay Support

Elligibility requirements:

  1. May have private/commercial insurance coverage (not a participant in federal or state-funded benefits program)
  2. Not Required
  3. Medically appropriate condition/diagnosis
  4. The patient must also be a US citizen.
  5. Health Care Providers must enroll in the program prior to processing the Amgen FIRST STEP Program Cards The card is valid for the patient's entire course of treatment. Eligible patients may re-enroll at any time a new course of treatment is initiated.

Applicable drugs:

  • Mvasi (bevacizumab-awwb) Injection; IV

Provider: Amgen Safety Net Foundation (ASNF)

Elligibility requirements:

  1. Must be uninsured or underinsured
  2. At or below 500% of FPL
  3. *See Additional Information section below
  4. Yes, must have lived in the US or its territories for 6 months or longer.
  5. Please visit ( ( for more information. * Diagnosis is required if patient has insurance.

Applicable drugs:

  • Mvasi (bevacizumab-awwb) Injection; IV

Provider: HealthWell Foundation Copay Program

Elligibility requirements:

  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.

Applicable drugs:

  • Mvasi (bevacizumab-awwb) Solution; IV (Infusion)

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Mvasi (bevacizumab-awwb) Solution; IV (Infusion)